Alveolar rhabdomyosarcoma with multiple bone marrow infiltration - 03/05/23
Doi : 10.1016/S1470-2045(23)00015-3
Kun Wang, MM a, Zhihong Chen, MD a, ⁎ 
, Yanchun Li, MD a, Zhiqun Mao, MD b
, Yanchun Li, MD a, Zhiqun Mao, MD b a Department of Pathology, Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan, China
b Department of PET/CT, Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan, China
* Correspondence to: Dr Zhihong Chen, Department of Pathology, Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha 410005, Hunan, China Department of Pathology Hunan Provincial People’s Hospital The First Affiliated Hospital of Hunan Normal University Changsha Hunan 410005 China
Le texte complet de cet article est disponible en PDF.
© 2023
Elsevier Ltd. Tous droits réservés.
Vol 24 - N° 5
P. e228 - mai 2023 Retour au numéro
Article précédent
- REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment
- Ehsan Ghorani, Matteo Quartagno, Fiona Blackhall, Duncan C Gilbert, Mary O’Brien, Christian Ottensmeier, Elena Pizzo, James Spicer, Alex Williams, Philip Badman, Mahesh K B Parmar, Michael J Seckl, REFINE-Lung Investigators
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?